Tritin Tran

Synthesis and Biologic Evaluation of a Novel ¹⁸F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

David J. Donnelly, R. Adam Smith, Paul E. Morin et al. · Journal of Nuclear Medicine · 2017 · 192 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4

Hwei‐Ru Tsou, Xiaoxiang Liu, Gary H. Birnberg et al. · Journal of Medicinal Chemistry · 2009 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

4-(Phenylaminomethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 (CDK4)

Hwei‐Ru Tsou, Mercy Otteng, Tritin Tran et al. · Journal of Medicinal Chemistry · 2008 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement

David J. Donnelly, Joon‐Young Kim, Tritin Tran et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 25 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase

David J. Donnelly, Sean Preshlock, Tanpreet Kaur et al. · Frontiers in Nuclear Medicine · 2022 · 13 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17